// App-Quantinova.ai

13907 : Patients With NSTEMI Are at Higher Risk, Have Worse Outcomes, but Less Intense Cardiology Follow-up 1-3 Years Post-discharge: Findings From the TIGRIS Registry

Researchers

Presenter

  • Sibi N Krishnamurthy

Principal Investigators

  • Stuart Pocock

  • Prashant Kaul

  • Ruth Owen

  • Jiyan Chen

  • Shaun G Goodman

  • Christopher B Granger

  • Jose C Nicolau

  • Tabassome Simon

  • Dirk Westermann

  • Satoshi Yasuda

  • Karolina Andersson-Sundell

  • Gunnar Brandrup-Wognsen

  • Phillip Hunt

  • David Brieger

  • Mauricio G Cohen

Medical Centers

  • University of Miami Miller School of Medicine, Miami, FL

  • London School of Hygiene and Tropical Medicine, London, United Kingdom

  • Piedmont Heart Institute, Atlanta, GA

  • Guangdong General Hosp, Provincial Key Laboratory of Coronary Disease, Guangzhou, China

  • Terrence Donnelly Heart Centre, St Michael's Hospital, University of Toronto, Toronto, Canada

  • Duke Medcl Ctr, Durham, NC

  • Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de, São Paulo, Brazil

  • Dept of Clinical Pharmacology, Assistance Publique-Hopitaux de Paris, Hopital St Antoine (APHP.SU), Sorbonne-Université, Paris, France

  • General and Interventional Cardiology, University Heart Center Hamburg-Eppendorf, Hamburg, Germany

  • Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan

  • AstraZeneca, Gothenburg, Sweden

  • AstraZeneca, Gaithersburg, MD

  • Concord Hosp and Univ of Sydney, Sydney, Australia

Locations

  • United States

  • United Kingdom

  • China

  • Canada

  • Brazil

  • France

  • Germany

  • Japan

  • Sweden

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved